ACADIA Pharmaceuticals CEO Stephen Davis' 2021 pay jumps 26% to $9.8M
ACADIA Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
ACADIA Pharmaceuticals reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, six executives at ACADIA Pharmaceuticals received on average a compensation package of $4.2M, a 7% increase compared to previous year.
Average pay of disclosed executives at ACADIA Pharmaceuticals
Stephen R. Davis, Chief Executive Officer, received $9.8M in total, which increased by 26% compared to 2020. 45% of Davis' compensation, or $4.4M, was in option awards. Davis also received $197K in non-equity incentive plan, $793K in salary, $4.4M in stock awards, as well as $45K in other compensation.
For fiscal year 2021, the median employee pay was $219,387 at ACADIA Pharmaceuticals. Therefore, the ratio of Stephen R. Davis' pay to the median employee pay was 45 to one.
Srdjan R. Stankovic, President, received a compensation package of $4.9M, which is about the same as previous year. 41% of the compensation package, or $2M, was in option awards.
Mark C. Schneyer, Chief Financial Officer, earned $3.2M in 2021.
Brendan P. Teehan, Chief Operating Officer, received $2.5M in 2021.
Elena H. Ridloff, Chief Financial Officer, earned $2.4M in 2021, a 5% decrease compared to previous year.
Austin D. Kim, General Counsel, received $2.3M in 2021, which increases by 33% compared to 2020.
Related executives
Stephen Davis
ACADIA Pharmaceuticals
Chief Executive Officer
Srdjan Stankovic
ACADIA Pharmaceuticals
President
Austin Kim
ACADIA Pharmaceuticals
General Counsel
Elena Ridloff
ACADIA Pharmaceuticals
Chief Financial Officer
Mark Schneyer
ACADIA Pharmaceuticals
Chief Financial Officer
Brendan Teehan
ACADIA Pharmaceuticals
Chief Operating Officer
You may also like
Source: SEC filing on April 29, 2022.